Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113062653 | 11306265 | 3 | F | 20160628 | 20160706 | 20150723 | 20160712 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-39139YA | BOEHRINGER INGELHEIM | 75.23 | YR | M | Y | 0.00000 | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113062653 | 11306265 | 1 | PS | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | 20579 | CAPSULE | ||||||||||
| 113062653 | 11306265 | 2 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MG | 1489999PC,1526647PC | 0 | 160 | MG | CAPSULE | QD | |||||
| 113062653 | 11306265 | 3 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 4 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 5 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 6 | SS | CARDURA | DOXAZOSIN MESYLATE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 7 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 8 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | FORMULATION: FINE GRANULE, 50 % | 0 | GRANULES | |||||||||
| 113062653 | 11306265 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 10 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 11 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 12 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 13 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 14 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 15 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 16 | C | PLETAL | CILOSTAZOL | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 17 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 18 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 19 | C | SANCTURA | TROSPIUM CHLORIDE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 20 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 21 | C | THIAMINE. | THIAMINE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 22 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | Unknown | 0 | |||||||||||
| 113062653 | 11306265 | 23 | C | MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113062653 | 11306265 | 1 | Product used for unknown indication |
| 113062653 | 11306265 | 2 | Hormone-refractory prostate cancer |
| 113062653 | 11306265 | 3 | Product used for unknown indication |
| 113062653 | 11306265 | 4 | Product used for unknown indication |
| 113062653 | 11306265 | 5 | Product used for unknown indication |
| 113062653 | 11306265 | 6 | Product used for unknown indication |
| 113062653 | 11306265 | 7 | Product used for unknown indication |
| 113062653 | 11306265 | 8 | Product used for unknown indication |
| 113062653 | 11306265 | 9 | Product used for unknown indication |
| 113062653 | 11306265 | 10 | Product used for unknown indication |
| 113062653 | 11306265 | 11 | Product used for unknown indication |
| 113062653 | 11306265 | 12 | Product used for unknown indication |
| 113062653 | 11306265 | 13 | Product used for unknown indication |
| 113062653 | 11306265 | 14 | Product used for unknown indication |
| 113062653 | 11306265 | 15 | Product used for unknown indication |
| 113062653 | 11306265 | 16 | Product used for unknown indication |
| 113062653 | 11306265 | 17 | Product used for unknown indication |
| 113062653 | 11306265 | 18 | Product used for unknown indication |
| 113062653 | 11306265 | 19 | Product used for unknown indication |
| 113062653 | 11306265 | 20 | Product used for unknown indication |
| 113062653 | 11306265 | 21 | Product used for unknown indication |
| 113062653 | 11306265 | 22 | Product used for unknown indication |
| 113062653 | 11306265 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113062653 | 11306265 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113062653 | 11306265 | Abdominal pain upper | |
| 113062653 | 11306265 | Death | |
| 113062653 | 11306265 | Drug interaction | |
| 113062653 | 11306265 | Inappropriate schedule of drug administration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |